Causes and consequences of low grade endotoxemia and inflammatory diseases

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 2, 2013, Pages 754-765

  Glaros, Trevor G ^a   Chang, Samantha ^a   Gilliam, Elizabeth A ^a   Maitra, Urmila ^a   Deng, Hui ^a   Li, Liwu ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Chronic diseases; Endotoxemia; Low grade inflammation; Mechanisms; Review

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ALCOHOL; APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CARCINOGEN; CHYLOMICRON; CIGARETTE SMOKE; ENDOTOXIN; FATTY ACID; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIVER X RECEPTOR ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PYRUVATE DEHYDROGENASE KINASE 4; RNA 16S; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

AGING; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; ATHEROSCLEROSIS; BACTERIAL COLONIZATION; BRAIN INJURY; CARDIOMYOPATHY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTOXEMIA; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; GLUCOSE OXIDATION; HUMAN; INFLAMMATORY DISEASE; INSULIN RESISTANCE; LIPID DIET; LIPID OXIDATION; LIPID STORAGE; LIPOTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERIODONTITIS; PORPHYROMONAS; REVIEW; SMOKING; ANIMAL; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; ENDOTOXEMIA; ENDOTOXINS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES;

EID: 84883240518     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s405     Document Type: Review

References (100)

1. H Terawaki, K Yokoyama, Y Yamada, Y Maruyama, R Iida, K Hanaoka, H Yamamoto, T Obata, T Hosoya. Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method. Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 14, 477-82 (2010)
2. JM Moreno-Navarrete, M Manco, J Ibáñez, E García-Fuentes, F Ortega, E Gorostiaga, J Vendrell, M Izquierdo, C Martínez, G Nolfe, W Ricart, G Mingrone, F Tinahones, JM Fernández-Real. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. International journal of obesity 34, 240-9 (2010)
3. PD Cani, R Bibiloni, C Knauf, A Waget, AM Neyrinck, NM Delzenne, R Burcelin. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-81 (2008)
4. T Goto, S Edén, G Nordenstam, V Sundh, C Svanborg-Edén, I Mattsby-Baltzer. Endotoxin levels in sera of elderly individuals. Clinical and diagnostic laboratory immunology 1, 684-8 (1994)
5. P Ancuta, A Kamat, KJ Kunstman, EY Kim , P Autissier, A Wurcel, T Zaman, D Stone, M Mefford, S Morgello, EJ Singer, SM Wolinsky, D Gabuzda. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3, e2516 (2008)
6. CJ Wiedermann, S Kiechl, S Dunzendorfer, P Schratzberger, G Egger, F Oberhollenzer, J Willeit. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. Journal of the American College of Cardiology 34, 1975-81 (1999)
7. R Rao. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50, 638-44 (2009)
8. FS Lira, JC Rosa , GD Pimentel, HA Souza, EC Caperuto, LC Carnevali Jr, M Seelaender, AR Damaso, LM Oyama, MT de Mello, RV Santos. Endotoxin levels correlate positively with a sedentary lifestyle and negatively with highly trained subjects. Lipids in health and disease 9, 82 (2010)
9. U Maitra, L Gan, S Chang, L Li. Low-dose endotoxin induces inflammation by selectively removing nuclear receptors and activating CCAAT/enhancer-binding protein delta. J Immunol 186, 4467-73 (2011)
10. F Laugerette, C Vors, A Géloën, MA Chauvin, C Soulage, S Lambert-Porcheron, N Peretti, M Alligier, R Burcelin, M Laville, H Vidal, MC Michalski. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. The Journal of nutritional biochemistry 22, 53-9 (2011)
11. U Maitra, H Deng, T Glaros, B Baker, DG Capelluto, Z Li, L Li. Molecular Mechanisms Responsible for the Selective and Low-Grade Induction of Proinflammatory Mediators in Murine Macrophages by Lipopolysaccharide. Journal of immunology 89, 1014-23 (2012)
12. VL Massey, GE Arteel. Acute alcohol-induced liver injury. Frontiers in physiology 3, 193 (2012)
13. A George, VM Figueredo. Alcoholic cardiomyopathy: a review. Journal of cardiac failure 17, 844-9 (2011)
14. MI Queipo-Ortuno, M Boto-Ordóñez, M Murri, JM Gomez-Zumaquero, M Clemente-Postigo, R Estruch, F Cardona Diaz, C Andrés-Lacueva, FJ Tinahones. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. The American journal of clinical nutrition 95, 1323-34 (2012)
15. AW Yan, B Schnabl. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World journal of hepatology 4, 110-8 (2012)
16. MJ Wasserman, NR Belton, JG Millichap, Effect of corticotropin (ACTH) on experimental seizures. Adrenal independence and relation to intracellular brain sodium. Neurology 15, 1136-41 (1965)
17. M Wassermann, M Gon, D Wassermann, L Zellermayer. Ddt and Dde in the Body Fat of People in Israel. Archives of environmental health 11, 375-9 (1965)
18. GT Durrer, HD Ayers, JW Benfield, KC Deesen, EH Getz, B Wasserman. New developments in dentistry. Annals of dentistry 24, 62-8 (1965)
19. HP Wassermann. The circulation of melanin-its clinical and physiological significance. Review of literature on leucocytic melanin transport. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 39, 711-6 (1965)
20. KS Lau, C Gottlieb, LR Wasserman, V Herbert. Measurement of Serum Vitamin B12 Level Using Radioisotope Dilution and Coated Charcoal. Blood 26, 202-14 (1965)
21. BF Erlanger, SM Vratsanos, N Wassermann, AG Cooper. Specific and Reversible Inactivation of Pepsin. The Journal of biological chemistry 240, PC3447-8 (1965)
22. NR Gevirtz, D Tendler, G Lurinsky, LR Wasserman. Case Records of the Massachusetts General Hospital. Case 30-1965. The New England journal of medicine 273, 98-106 (1965)
23. J Guydish, B Tajima, ST Manser, M Jessup. Strategies to encourage adoption in multisite clinical trials. Journal of substance abuse treatment 32, 177-88 (2007)
24. EN Glaros, WS Kim, BJ Wu, C Suarna, CM Quinn, KA Rye, R Stocker, W Jessup, B Garner. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochemical pharmacology 73, 1340-6 (2007)
25. DM van Reyk, AJ Brown, LM Hult'en, RT Dean, W Jessup. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox report: communications in free radical research 11, 255-62 (2006)
26. WS Kim, AS Rahmanto, A Kamili, KA Rye, GJ Guillemin, IC Gelissen, W Jessup, AF Hill, B Garner. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. The Journal of biological chemistry 282, 2851-61 (2007)
27. WA Miller, MA Miller, IA Gardner, ER Atwill, BA Byrne, S Jang, M Harris, J Ames, D Jessup, D Paradies, K Worcester, A Melli, PA Conrad. Salmonella spp., Vibrio spp., Clostridium perfringens, and Plesiomonas shigelloides in marine and freshwater invertebrates from coastal California ecosystems. Microbial ecology 52, 198-206 (2006)
28. P Terech, S Dourdain, U Maitra, S Bhat. Structure and rheology of cationic molecular hydrogels of quinuclidine grafted bile salts. Influence of the ionic strength and counterion type. The journal of physical chemistry 113, 4619-30 (2009)
29. EJ Gallagher, D Leroith, E Karnieli. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. The Mount Sinai journal of medicine 77, 511-23 (2010)
30. EJ Gallagher, D LeRoith. The proliferating role of insulin and insulin-like growth factors in cancer. Trends in endocrinology and metabolism: TEM 21, 610-8 (2010)
31. SE Shoelson, J Lee, AB Goldfine. Inflammation and insulin resistance. The Journal of clinical investigation 116, 1793-801 (2006)
32. G Solinas, C Vilcu, JG Neels, GK Bandyopadhyay, JL Luo, W Naugler, S Grivennikov, A Wynshaw-Boris, M Scadeng, JM Olefsky, M Karin. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell metabolism 6, 386-97 (2007)
33. H Nakarai, A Yamashita, S Nagayasu, M Iwashita, S Kumamoto, H Ohyama, M Hata, Y Soga, A Kushiyama, T Asano, Y Abiko, F Nishimura. Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications. Innate immunity 18, 164-70 (2012)
34. EJ Gallagher, D LeRoith. Insulin, insulin resistance, obesity, and cancer. Current diabetes reports 10, 93-100 (2010)
35. W Yang, D Qiang, M Zhang, L Ma, Y Zhang, C Qing, Y Xu, C Zhen, J Liu, YH Chen. Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models. International immunopharmacology 11, 683-92 (2011)
36. R Jin, B Zhang, SM Liu, L Ni, M Li, LZ Li. [Mathematical analysis of characteristics of glucocorticoidinduced yang deficiency or yin deficiency syndrome in animal models based on information entropy theory]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 9, 15-21 (2011)
37. L Qin, X Wu, ML Block, Y Liu. Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-62 (2007)
38. W Pan, AJ Kastin. TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. Experimental neurology 174, 193-200 (2002)
39. HM Gao, J Jiang, B Wilson, W Zhang, JS Hong, B Liu. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. Journal of neurochemistry 81, 1285-97 (2002)
40. BA George, JM Ko, FD Lensing, JJ Kuiper, WC Roberts. "Repaired" tetralogy of fallot mimicking arrhythmogenic right ventricular cardiomyopathy (another phenocopy). The American journal of cardiology 108, 326-9 (2011)
41. NR Gevirtz, D Tendler, G Lurinsky, LR Wasserman. Clinical Studies of Storage Iron with Desferrioxamine. The New England journal of medicine 273, 95-7 (1965)
42. E Smith, S Kochwa, LR Wasserman. Aggregation of Igg Globulin in vivo. I. The Hyperviscosity Syndrome in Multiple Myeloma. The American journal of medicine 39, 35-48 (1965)
43. L Sharney, LR Wasserman, NR Gevirtz, L Schwartz, D Tendler. Multiple-Pool Analysis in Tracer Studies of Metabolic Kinetics. Ii. Three-Pool Models and Partial Systems. Journal of the Mount Sinai Hospital 32, 236-61 (1965)
44. L Wasserman, L Gavrilita. [Contributions to the morphopathology of the intramural nervous system of the stomach in peptic ulcer]. Studii si cercetari de neurologie 10, 429-37 (1965)
45. J Wasserman, T Packalen. Immune responses to thyroglobulin in experimental allergic thyroiditis. Immunology 9, 1-10 (1965)
46. F Wasserman. The development of adipose tissue. In Handbook of Physiology. Section 5: Adipose Tissue, 87-100 (1965)
47. T Suganami, J Nishida, Y Ogawa. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arteriosclerosis, thrombosis, and vascular biology 25, 2062-8 (2005)
48. A Gastaldelli, Y Miyazaki, M Pettiti, M Matsuda, S Mahankali, E Santini, RA DeFronzo, E Ferrannini. Metabolic effects of visceral fat accumulation in type 2 diabetes. The Journal of clinical endocrinology and metabolism 87, 5098-103 (2002)
49. P Wiesner, SH Choi, F Almazan, C Benner, W Huang, CJ Diehl, A Gonen, S Butler, JL Witztum, CK Glass, YI Miller. Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circulation research 107, 56-65 (2010)
50. A Kleinridders, D Schenten, AC Könner, BF Belgardt, J Mauer, T Okamura, FT Wunderlich, R Medzhitov, JC Brüning. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell metabolism 10, 249-59 (2009)
51. EA Kaperonis, CD Liapis, JD Kakisis, D Perrea, AG Kostakis, PE Karayannakos. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology. Journal of vascular surgery: official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 44, 1198-204 (2006)
52. PJ Pussinen, AS Havulinna, M Lehto, J Sundvall, V Salomaa. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes care 34, 392-7 (2011)
53. JM Olefsky, CK Glass, Macrophages, inflammation, and insulin resistance. Annual review of physiology 72, 219-46 (2010)
54. J Hirosumi, G Tuncman, L Chang, CZ Görgün, KT Uysal, K Maeda, M Karin, GS Hotamisligil. A central role for JNK in obesity and insulin resistance. Nature 420, 333-6 (2002)
55. G Solinas, M Karin. JNK1 and IKKbeta: Molecular links between obesity and metabolic dysfunction. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 24, 2596-611 (2010)
56. M Manco, L Putignani, GF Bottazzo. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocrine reviews 31, 817-44 (2010)
57. R Vijayvargia, K Mann, HR Weiss, HJ Pownall, H Ruan. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes. Obesity 18, 1701-9 (2010)
58. Z Gerhart-Hines, JT Rodgers, O Bare, C Lerin, SH Kim, R Mostoslavsky, FW Alt, Z Wu, P Puigserver. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. The EMBO journal 26, 1913-23 (2007)
59. JF Tanti, T Grémeaux, E van Obberghen, Y Le Marchand-Brustel. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. The Journal of biological chemistry 269, 6051-7 (1994)
60. PE Scherer. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537-45(2006)
61. EA Kaperonis., CD Liapis, JD Kakisis, D Dimitroulis, VG Papavassiliou. Inflammation and atherosclerosis. European journal of vascular and endovascular surgery: The official journal of the European Society for Vascular Surgery 31, 386-93 (2006)
62. H Ghanim, S Abuaysheh, CL Sia, K Korzeniewski, A Chaudhuri, JM Fernandez-Real, P Dandona. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes care 32, 2281-7 (2009)
63. JB Rice, LL Stoll, WG Li, GM Denning, J Weydert, E Charipar, WE Richenbacher, FJ Miller Jr, NL Weintraub. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arteriosclerosis, thrombosis, and vascular biology 23, 1576-82 (2003)
64. MA Miller, PG McTernan, AL Harte, NF Silva, P Strazzullo, KG Alberti, S Kumar, FP Cappuccio. Ethnic and sex differences in circulating endotoxin levels: A novel marker of atherosclerotic and cardiovascular risk in a British multiethnic population. Atherosclerosis 203, 494-502 (2009)
65. LL Stoll, GM Denning, NL Weintraub. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 24, 2227-36 (2004)
66. LK Curtiss, PS Tobias. Emerging role of Toll-like receptors in atherosclerosis. Journal of lipid research 50, S340-5 (2009)
67. K Yin, DF Liao, CK Tang. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Molecular medicine 16, 438-49 (2010)
68. A Majdalawieh, HS Ro. LPS-induced suppression of macrophage cholesterol efflux is mediated by adipocyte enhancer-binding protein 1. The international journal of biochemistry & cell biology 41, 1518-25 (2009)
69. U Maitra, JS Parks, L Li. An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2. Mol Cell Biol 29, 5989-97 (2009)
70. C Tang, Y Liu, PS Kessler, AM Vaughan, JF Oram. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. The Journal of biological chemistry 284, 32336-43 (2009)
71. W Jessup, IC Gelissen, K Gaus, L Kritharides. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Current opinion in lipidology 17, 247-57 (2006)
72. X Wang, HL Collins, M Ranalletta, IV Fuki, JT Billheimer, GH Rothblat, AR Tall, DJ Rader. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. The Journal of clinical investigation 117, 2216-24 (2007)
73. Y Park, TX Pham, J Lee. Lipopolysaccharide represses the expression of ATP-binding cassette transporter G1 and scavenger receptor class B, type I in murine macrophages. Inflammation research 61, 465-72 (2012)
74. I Meurs, B Lammers, Y Zhao, R Out, RB Hildebrand, M Hoekstra, TJ Van Berkel, M Van Eck. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Atherosclerosis 221, 41-7 (2012)
75. RR Packard, AH Lichtman, P Libby. Innate and adaptive immunity in atherosclerosis. Seminars in immunopathology 31, 5-22 (2009)
76. P Libby, M DiCarli, R Weissleder. The vascular biology of atherosclerosis and imaging targets. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 51, 33S-37S (2010)
77. G Dutta, P Zhang, B Liu. The lipopolysaccharide Parkinson's disease animal model: Mechanistic studies and drug discovery. Fundamental & clinical pharmacology 22, 453-64 (2008)
78. S Walter, M Letiembre, Y Liu, H Heine, B Penke, W Hao, B Bode, N Manietta, J Walter, W Schulz-Schuffer, K Fassbender. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 20, 947-56 (2007)
79. M Liu, G Bing. Lipopolysaccharide animal models for Parkinson's disease. Parkinson's disease 2011, Article ID 327089 (2011)
80. HM Gao, H Zhou, F Zhang, BC Wilson, W Kam, JS Hong. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. The Journal of neuroscience: The official journal of the Society for Neuroscience 31, 1081-92 (2011)
81. W Pan, AJ Kastin, J Daniel, C Yu, LM Baryshnikova, CS von Bartheld. TNFalpha trafficking in cerebral vascular endothelial cells. Journal of neuroimmunology 185, 47-56 (2007)
82. L Qin, J He, RN Hanes, O Pluzarev, JS Hong, FT Crews. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. Journal of neuroinflammation 5, 10 (2008)
83. R Kacimi, RG Giffard, MA Yenari. Endotoxinactivated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways. Journal of inflammation 8, 7 (2011)
84. N Leitinger. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans. Subcellular biochemistry 49, 325-50 (2008)
85. M Morris, L Li. Molecular mechanisms and pathological consequences of endotoxin tolerance and priming. Archivum immunologiae et therapiae experimentalis 60, 13-8 (2012)
86. SK Biswas, E Lopez-Collazo. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends in immunology 30, 475-87 (2009)
87. B Chaurasia, J Mauer, L Koch, J Goldau, AS Kock, JC Brüning. Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages. Molecular and cellular biology 30, 4354-66 (2010)
88. J Brown, H Wang, GN Hajishengallis, M Martin. TLRsignaling networks: an integration of adaptor molecules, kinases, and cross-talk. Journal of dental research 90, 417-27 (2011)
89. K Kondoh, E Nishida. Regulation of MAP kinases by MAP kinase phosphatases. Biochimica et biophysica acta 1773, 1227-37 (2007)
90. L Li, SF Chen, Y Liu. MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. International journal of clinical and experimental medicine 2, 48-67 (2009)
91. T Glaros, Y Fu, J Xing, L Li. Molecular mechanism underlying persistent induction of LCN2 by lipopolysaccharide in kidney fibroblasts. PLoS One 7, e34633 (2012)
92. T Glaros, M Larsen, L Li. Macrophages and fibroblasts during inflammation, tissue damage and organ injury. Frontiers in bioscience: a journal and virtual library 14, 3988-93 (2009)
93. BB Chorinchath, LY Kong, L Mao, RE McCallum. Ageassociated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol 156, 1525-30 (1996)
94. P Wassermann. [Examination of a New Impression Material with an Alginate Basis (Protex-L)]. Deutsche zahnarztliche Zeitschrift 20, 159-62 (1965)
95. B Urbaschek, R Urbaschek, G Mauff, C Gerlach, K Huth, F Jung, RH Ringert, A Nowotny, H Fritsch. Long term toxicity studies with endotoxoid in monkeys. Experientia 27, 803-5 (1971)
96. B Urbaschek, R Urbaschek. The inflammatory response to endotoxins. Bibl Anat 17, 74-104 (1979)
97. R Urbaschek, B Urbaschek. Aspects of beneficial endotoxin-mediated effects. Klin Wochenschr 60, 746-8 (1982)
98. RS McCuskey, PA McCuskey, R Urbaschek, B Urbaschek. Species differences in Kupffer cells and endotoxin sensitivity. Infect Immun 45, 278-80 (1984)
99. LT van Eijk, MJ Dorresteijn, P Smits, JG van der Hoeven, MG Netea, P Pickkers. Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med 35, 1464-9 (2007)
100. SV Aulock, S Deininger, C Draing, K Gueinzius, O Dehus, C Hermann. Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J Interferon Cytokine Res 26, 887-92 (2006)